南京奥昭生物科技有限公司在南京市321 人才项目支持下2012年注册成立的中外合资小分子化学新药研发企业，重点是从事抗肿瘤和治疗炎症疾病一类新药的研发。公司创始人有20多年在跨国药企的工作经验，目前已有数个抗肿瘤靶向药物在不同的临床前研发阶段。公司前景辉煌，技术力量雄厚，在员工的共同努力下，将会成以研发为基础的国内一流药物企业。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
